1. 1399PImpact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Peters, S; Shaw, A T; Besse, B; Felip, E; Solomon, B J; Soo, R A; Bearz, A; Gadgee, S M; Lin, C-C; Kao, S; Seto, T; Masters, E T; Abbattista, A; Clancy, J S; Thurm, H; Reisman, A; Camidge, D R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of high-density lipoprotein levels in males and females undergoing percutaneous coronary intervention with drug eluting stents. (25th November 2020) Authors: Roumeliotis, A; Mehran, R; Claessen, B; Sartori, S; Cao, D; Chandiramani, R; Nicolas, J; Goel, R; Reisman, A; Baber, U; Sweeny, J; Barman, N; Dangas, G; Sharma, S; Kini, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗